257 related articles for article (PubMed ID: 38421488)
1. The pathogenesis of cancer-associated thrombosis.
Tatsumi K
Int J Hematol; 2024 May; 119(5):495-504. PubMed ID: 38421488
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated pathways and biomarkers of venous thrombosis.
Hisada Y; Mackman N
Blood; 2017 Sep; 130(13):1499-1506. PubMed ID: 28807983
[TBL] [Abstract][Full Text] [Related]
3. Deep venous thrombosis.
López JA; Kearon C; Lee AY
Hematology Am Soc Hematol Educ Program; 2004; ():439-56. PubMed ID: 15561697
[TBL] [Abstract][Full Text] [Related]
4. Histopathological Features of Cancer-Associated Venous Thromboembolism: Presence of Intrathrombus Cancer Cells and Prothrombotic Factors.
Gi T; Kuwahara A; Yamashita A; Matsuda S; Maekawa K; Moriguchi-Goto S; Sato Y; Asada Y
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):146-159. PubMed ID: 36384269
[TBL] [Abstract][Full Text] [Related]
5. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
Hisada Y; Mackman N
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
[TBL] [Abstract][Full Text] [Related]
6. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
[TBL] [Abstract][Full Text] [Related]
7. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Hisada Y; Di Nisio M; Cesarman G; Kleinjan A; Mahé I; Otten HM; Kamphuisen PW; Berckmans RJ; Büller HR; Mackman N; Nieuwland R
Thromb Res; 2018 Jun; 166():54-59. PubMed ID: 29656167
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.
Thomas GM; Brill A; Mezouar S; Crescence L; Gallant M; Dubois C; Wagner DD
J Thromb Haemost; 2015 Jul; 13(7):1310-9. PubMed ID: 25955268
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy.
Yao M; Ma J; Wu D; Fang C; Wang Z; Guo T; Mo J
Front Immunol; 2023; 14():1198952. PubMed ID: 37680629
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
13. [Tissue factors and venous thromboembolism in cancer patients].
Zhu H; Ying K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 49(6):772-778. PubMed ID: 33448181
[TBL] [Abstract][Full Text] [Related]
14. Venous thrombosis and cancer: from mouse models to clinical trials.
Hisada Y; Geddings JE; Ay C; Mackman N
J Thromb Haemost; 2015 Aug; 13(8):1372-82. PubMed ID: 25988873
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps.
Boone BA; Murthy P; Miller-Ocuin J; Doerfler WR; Ellis JT; Liang X; Ross MA; Wallace CT; Sperry JL; Lotze MT; Neal MD; Zeh HJ
BMC Cancer; 2018 Jun; 18(1):678. PubMed ID: 29929491
[TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis (DVT) and pulmonary embolism (PE): awareness and prophylaxis practices reported by patients with cancer.
Aggarwal A; Fullam L; Brownstein AP; Maynard GA; Ansell J; Varga EA; Friedman RJ; Rickles FR
Cancer Invest; 2015; 33(9):405-10. PubMed ID: 26181096
[TBL] [Abstract][Full Text] [Related]
17. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer.
Willems RAL; Biesmans C; Campello E; Simioni P; de Laat B; de Vos-Geelen J; Roest M; Ten Cate H
Semin Thromb Hemost; 2024 Apr; 50(3):429-442. PubMed ID: 38049115
[TBL] [Abstract][Full Text] [Related]
18. Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.
Corley AM; Sullivan MJ; Friedman SE; O'Rourke DJ; Palac RT; Gemignani AS
Am J Cardiol; 2019 Feb; 123(4):679-683. PubMed ID: 30528279
[TBL] [Abstract][Full Text] [Related]
19. Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.
Jiménez-Alcázar M; Limacher A; Panda R; Méan M; Bitterling J; Peine S; Renné T; Beer JH; Aujesky D; Lämmle B; Fuchs TA
PLoS One; 2018; 13(2):e0191150. PubMed ID: 29474368
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer.
Li JC; Zou XM; Yang SF; Jin JQ; Zhu L; Li CJ; Yang H; Zhang AG; Zhao TQ; Chen CY
World J Gastroenterol; 2022 Jul; 28(26):3132-3149. PubMed ID: 36051331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
